Drug Discovery & Research
AI Slashes Cancer Drug Development Costs by 90%, Biotech Claims—But Can the Model Scale?
Lantern Pharma reports its artificial intelligence platform reduces early-stage oncology development costs to $2-3 million per program, a fraction of traditional industry spending, while spinning out the technology as a commercial software business.
Health AI Central Editorial Team·August 17, 2026